|
Market Closed -
NYSE
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.640 USD | -3.30% |
|
-1.12% | +46.67% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 04/09/2026 | 08/09/2026 | 09/09/2026 | 10/09/2026 | 11/09/2026 | |
|---|---|---|---|---|---|
| Last | $2.670 | $2.650 | $2.670 | $2.730 | $2.640 |
| Volume | 863,718 | 908,363 | 580,004 | 782,524 | 646,807 |
| Change | +1.91% | -0.75% | +0.75% | +2.25% | -3.30% |
| Opening | $2.620 | $2.660 | $2.680 | $2.660 | $2.740 |
| High | $2.680 | $2.670 | $2.680 | $2.735 | $2.750 |
| Low | $2.615 | $2.600 | $2.595 | $2.640 | $2.615 |
Performance
| 1 day | -3.30% | ||
| 1 week | -1.12% | ||
| Current month | +2.72% | ||
| 1 month | +8.64% | ||
| 3 months | +28.78% | ||
| 6 months | -8.65% | ||
| Current year | +46.67% | ||
| 1 year | +51.72% | ||
| 3 years | +50.86% | ||
| 5 years | +76.00% | ||
| 10 years | -57.28% |
Volumes
marketsDaily volume
646,807
Estimated daily volume
646,807
Avg. Volume 20 sessions
731,562
Daily volume ratio
0.88
Avg. Volume 20 sessions USD
1,931,323.68
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
212,709,134
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
204,460,707
Average Daily Capital Traded
0.91%
Indicators
Moving average 5 days
2.672
Moving average 20 days
2.492
Moving average 50 days
2.422
Moving average 100 days
2.256
Price spread / (MMA5)
+1.21%
Price spread / (MMA20)
-5.59%
Price spread / (MMA50)
-8.24%
Price spread / (MMA100)
-14.56%
RSI 9 days
73.89
RSI 14 days
68.06
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.30% | -1.12% | +51.72% | +50.86% | 213M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | |
| Average | -0.99% | -5.29% | +23.64% | +41.91% | 350.5B | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.71% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
0ca2935d8d5398da4f3f34f00.uGX748uVF7JIRe8cHxbzZdu0EBrEwYSYvz-_-Mblj3I.iCayiLnKI_EGP7prTiKrXI_aVGCvo-jR2VyLjI6g-jfyCM2ijbhF3n0UgA
| Date | Price | Volume | Total |
|---|---|---|---|
| 00:00:00 | 2.640 | 33,308 | 564,436 |
| 23:59:59 | 2.660 | 281 | 531,128 |
| 23:59:59 | 2.650 | 400 | 530,847 |
| 23:59:59 | 2.655 | 200 | 530,447 |
| 23:59:59 | 2.650 | 200 | 530,247 |
| 23:59:59 | 2.655 | 400 | 530,047 |
| 23:59:59 | 2.660 | 159 | 529,647 |
| 23:59:59 | 2.660 | 176 | 529,488 |
| 23:59:52 | 2.655 | 100 | 529,312 |
| 23:59:51 | 2.660 | 112 | 529,212 |
Price Extremes
| 1 week | 2.6 |  | 2.75 |
| 1 month | 2.17 | | 2.75 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +46.67% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
